3 ms·
> authority to organize and pay for clinical trials and toxicity studies. But further to that, if said executive does follow regulatory guidance and accepted p
by ska 6y ago
> authority to organize and pay for clinical trials and toxicity studies.
But further to that, if said executive does follow regulatory guidance and accepted practice but the product has a problem, should they really be held individually responsible?
For the clinical trials example, if a trial fails to turn up a significant problem, is it the exec's fault or the regulators? The regulators or the legislative body?
- whatshisface 6y agoOftentimes, regulatory bodies make companies immune to lawsuits in exchange for compliance. That leads to there being no incentive against creating products that are compliant, yet dangerous. It might be a good idea to reform the system so that harm is the ultimate decider.